Xintao Hu
- Virology top 5%
- HIV Research and Treatment 17
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment 6
- SARS-CoV-2 and COVID-19 Research 3
- HIV/AIDS Research and Interventions 3
-
- Immune Cell Function and Interaction 7
- Immunotherapy and Immune Responses 5
- Modeling and Simulation top 10%
-
- Cytomegalovirus and herpesvirus research 5
- Herpesvirus Infections and Treatments 3
Xintao Hu
22 papers receiving 349 citations
Hit Papers
Peers
Comparison fields: 5 of 52
- Virology 132
- Infectious Diseases 166
- Immunology 151
- Modeling and Simulation 21
- Epidemiology 89
Countries citing papers authored by Xintao Hu
This map shows the geographic impact of Xintao Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xintao Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xintao Hu more than expected).
Fields of papers citing papers by Xintao Hu
This network shows the impact of papers produced by Xintao Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xintao Hu. The network helps show where Xintao Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xintao Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses Than the gB/MF59 Vaccinebreakdown → | 2024 | 48 |
| 2 | 2022 | 3 | |
| 3 | 2022 | 17 | |
| 4 | 2021 | 12 | |
| 5 | 2021 | 48 | |
| 6 | 2021 | 4 | |
| 7 | 2021 | 26 | |
| 8 | 2021 | 7 | |
| 9 | 2020 | 1 | |
| 10 | 2019 | 4 | |
| 11 | 2018 | 13 | |
| 12 | 2017 | 2 | |
| 13 | 2017 | 4 | |
| 14 | 2017 | 13 | |
| 15 | 2016 | 31 | |
| 16 | 2016 | 29 | |
| 17 | 2015 | 11 | |
| 18 | 2013 | 18 | |
| 19 | 2012 | 18 | |
| 20 | 2012 | 17 |
About Xintao Hu
Xintao Hu is a scholar working on Virology, Infectious Diseases and Immunology, having authored 22 papers that have together received 356 indexed citations. Recurring topics across this work include HIV Research and Treatment (17 papers), Immune Cell Function and Interaction (7 papers), HIV/AIDS drug development and treatment (6 papers), Immunotherapy and Immune Responses (5 papers), Cytomegalovirus and herpesvirus research (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Herpesvirus Infections and Treatments (3 papers) and HIV/AIDS Research and Interventions (3 papers). The work is most often cited by research in Virology (132 citations), Infectious Diseases (166 citations) and Immunology (151 citations). Xintao Hu has collaborated with scholars based in United States, China and Greece. Frequent co-authors include Barbara K. Felber, George N. Pavlakis, Margherita Rosati, Yiming Shao, James I. Mullins, Candido Alicea, Jennifer A. Jenks, Jenifer Bear, Sallie R. Permar and Ioannis Ntanasis‐Stathopoulos. Their work appears in journals such as The Journal of Immunology, Scientific Reports and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.